The Patent Finder

Metabasis Therapeutics, Inc.

Also on record
Records under this name other than the patents Metabasis Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.

Back to Metabasis Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,563,746Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,329,914Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,410,284Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,394,969Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,440,502Use of Thyroid Beta-Agonists
Held by another company
In force
 · Low confidence
In forceLow confidence
US 7,582,758Lewis acid mediated synthesis of cyclic esters
Term ended
Term ended Nov 12, 2026 · USPTO record
Term endedTerm ended Nov 12, 2026USPTO record
US 7,829,552Phosphorus-containing thyromimetics
Term ended
Term ended Oct 20, 2026 · USPTO record
Term endedTerm ended Oct 20, 2026USPTO record
US 10,925,885Thyromimetics for the treatment of fatty liver diseases
Term ended
Term ended Jul 11, 2026 · USPTO record
Term endedTerm ended Jul 11, 2026USPTO record
US 7,666,8552′-C-methyl nucleoside derivatives
Term ended
Term ended Nov 6, 2024 · USPTO record
Term endedTerm ended Nov 6, 2024USPTO record
US 10,807,946Antagonists of the glucagon receptor
Lapsed on the fee record
Ended Oct 20, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 20, 2024USPTO record
10 of 68 patents shown.
Pro members see all 68.
Pro members: see all 68 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited